North West London Pathology (NWLP), hosted by Imperial College Healthcare NHS Trust, has announced a strategic partnership with global healthcare company Abbott to streamline their pathology services in three NHS Trusts.
The $252 million managed equipment services contract is for the supply of all analytical equipment and consumables to Imperial College Healthcare NHS Trust, Chelsea and Westminster NHS Foundation Trust, and the Hillingdon Hospitals NHS Foundation Trust.
Stephen Snewin, managing director of NWLP, said: "NWLP aims to provide an innovative and sustainable pathology service which delivers outstanding quality for our patients and clinicians. After a highly competitive process involving multiple diagnostic equipment manufacturers, NWLP is extremely excited to be working with Abbott, which supports our vision of increased efficiency and transformation across six major sites in North West London using the latest technology."
The partnership is expected to manage 26 million tests per year and currently holds 6% of the total pathology market in the UK.
Mike Clayton, managing director, Northern Europe, for Abbott's diagnostics business added: "Abbott is delighted to provide NWLP with personalized Alinity and AlinIQ solutions to help them navigate the challenges of an evolving healthcare system. Through our partnership, we will equip NWLP to help maximize productivity, drive faster delivery of test results and provide the critical information needed for clinical decisions – with the goal of helping the Trust improve patient outcomes."
